WesBanco Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
15,643
-1,635
-9% -$215K 0.05% 271
2026
Q1
$2.41M Sell
17,278
-1,205
-7% -$169K 0.07% 206
2025
Q4
$2.27M Sell
18,483
-1,981
-10% -$241K 0.06% 209
2025
Q3
$2.27M Sell
20,464
-4,321
-17% -$491K 0.06% 218
2025
Q2
$2.75M Buy
24,785
+5,228
+27% +$556K 0.08% 188
2025
Q1
$2.19M Sell
19,557
-230
-1% -$23.7K 0.08% 193
2024
Q4
$1.83M Sell
19,787
-739
-4% -$66.5K 0.06% 220
2024
Q3
$1.72M Buy
20,526
+364
+2% +$27.8K 0.06% 232
2024
Q2
$1.38M Sell
20,162
-405
-2% -$27K 0.05% 244
2024
Q1
$1.51M Buy
20,567
+7,927
+63% +$610K 0.06% 229
2023
Q4
$1.02M Sell
12,640
-8,353
-40% -$650K 0.06% 190
2023
Q3
$1.57M Sell
20,993
-507
-2% -$39K 0.07% 202
2023
Q2
$1.66M Sell
21,500
-549
-2% -$43.8K 0.07% 200
2023
Q1
$1.83M Sell
22,049
-837
-4% -$69.3K 0.08% 190
2022
Q4
$1.97M Buy
22,886
+7,786
+52% +$617K 0.09% 187
2022
Q3
$932K Sell
15,100
-17,547
-54% -$1.11M 0.06% 188
2022
Q2
$2.02M Sell
32,647
-1,875
-5% -$116K 0.09% 180
2022
Q1
$2.05M Sell
34,522
-15,494
-31% -$990K 0.08% 198
2021
Q4
$3.63M Sell
50,016
-1,084
-2% -$74.7K 0.13% 148
2021
Q3
$3.57M Sell
51,100
-70,594
-58% -$4.96M 0.14% 141
2021
Q2
$8.38M Sell
121,694
-184
-0.2% -$12.3K 0.31% 79
2021
Q1
$7.88M Buy
+121,878
New +$7.86M 0.31% 83
2020
Q3
$6.66M Buy
105,378
+61,861
+142% +$4.29M 0.31% 89
2020
Q2
$3.35M Sell
43,517
-2,729
-6% -$209K 0.16% 129
2020
Q1
$3.46M Buy
46,246
+14,081
+44% +$973K 0.2% 123
2019
Q4
$2.09M Sell
32,165
-5,821
-15% -$379K 0.1% 181
2019
Q3
$2.41M Buy
37,986
+9,997
+36% +$654K 0.12% 154
2019
Q2
$1.89M Sell
27,989
-1,002
-3% -$65.9K 0.09% 190
2019
Q1
$1.88M Buy
28,991
+929
+3% +$61.7K 0.09% 181
2018
Q4
$1.75M Buy
28,062
+4,480
+19% +$313K 0.1% 163
2018
Q3
$1.82M Sell
23,582
-985
-4% -$74.4K 0.09% 194
2018
Q2
$1.74M Sell
24,567
-12,907
-34% -$911K 0.09% 199
2018
Q1
$2.83M Buy
37,474
+11,238
+43% +$893K 0.14% 145
2017
Q4
$1.88M Sell
26,236
-1,751
-6% -$133K 0.13% 143
2017
Q3
$2.27M Sell
27,987
-667
-2% -$51K 0.12% 160
2017
Q2
$2.03M Buy
28,654
+125
+0.4% +$8.32K 0.11% 166
2017
Q1
$1.94M Buy
28,529
+697
+3% +$49K 0.11% 168
2016
Q4
$1.99M Sell
27,832
-3,125
-10% -$232K 0.11% 160
2016
Q3
$2.45M Buy
30,957
+335
+1% +$27.2K 0.14% 141
2016
Q2
$2.56M Sell
30,622
-20,869
-41% -$1.85M 0.15% 131
2016
Q1
$4.73M Buy
51,491
+1,185
+2% +$107K 0.28% 86
2015
Q4
$5.09M Buy
50,306
+775
+2% +$80.6K 0.3% 82
2015
Q3
$4.86M Buy
49,531
+804
+2% +$89.3K 0.29% 80
2015
Q2
$5.71M Sell
48,727
-6,854
-12% -$749K 0.32% 83
2015
Q1
$5.45M Buy
55,581
+750
+1% +$76.2K 0.3% 82
2014
Q4
$5.17M Buy
54,831
+9
+0% +$931 0.28% 90
2014
Q3
$5.84M Buy
54,822
+3,756
+7% +$368K 0.33% 81
2014
Q2
$4.23M Buy
51,066
+10,117
+25% +$787K 0.24% 96
2014
Q1
$2.9M Buy
40,949
+700
+2% +$54.9K 0.17% 118
2013
Q4
$3.02M Sell
40,249
-260
-0.6% -$18.1K 0.17% 115
2013
Q3
$2.55M Buy
40,509
+13,125
+48% +$784K 0.16% 122
2013
Q2
$1.4M Buy
+27,384
New +$1.43M 0.09% 163

Other funds holding GILD

WesBanco Bank's GILD Position: Q2 2026 in Review

WesBanco Bank reduced its Gilead Sciences (GILD) stake by 9.5% in Q2 2026, selling an estimated $215K and leaving 15,643 shares worth $1.98M. The position accounts for 0.05% of the portfolio, ranked #271.

WesBanco Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.38M in Q2 2021. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • WesBanco Bank held 15,643 shares of Gilead Sciences worth $1.98M as of Q2 2026.
  • WesBanco Bank sold 1,635 Gilead Sciences shares in Q2 2026, an estimated $215K.
  • Gilead Sciences made up 0.05% of WesBanco Bank's portfolio in Q2 2026, its #271 holding.
  • WesBanco Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • WesBanco Bank's Gilead Sciences position peaked at $8.38M in Q2 2021.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.